Return ONLY valid JSON. No markdown. Based on 7 medical records: DOCUMENT: PSA by Year.docx (Lab Result) Date:...

April 2, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

Return ONLY valid JSON. No markdown. Based on 7 [ID removed] DOCUMENT: PSA by Year.docx (Lab Result) Date: 2020-2025 Summary: This shows your PSA blood test results over 5 years, from 2020 to 2025. PSA is a protein made by the prostate gland, and your levels have gradually increased from 1.9 to 4.22. While still in the norma... Diagnosis: PSA monitoring, possible prostate concerns Cancer Type: unknown Stage: unknown Biomarkers: PSA Key Labs: PSA 2020: 1.9, PSA 2022: 3.6, PSA 2023: 3.23, PSA 2024: 3.95, PSA June 2025: 4.1 Next Steps: discuss trending PSA values with urologist --- DOCUMENT: Oct 2025 PSA.png (Lab Result) Date: Oct 07, 2025 2:30 PM Summary: This is a PSA blood test that measures prostate-specific antigen levels. The total PSA is elevated at 4.22, which is above the normal range of less than 4.00. The free PSA percentage is low at 14%, wh... Diagnosis: unknown Cancer Type: unknown Stage: unknown Biomarkers: PSA, Free PSA Key Labs: Free PSA: 0.61, Prostate Specific Ag-Diagnostic: 4.22, % Free PSA: 14 Next Steps: unknown --- DOCUMENT: June 2025 PSA.png (Lab Result) Date: [date removed] Summary: This is a PSA blood test result showing a level of 4.1 NG/mL, which is marked as high. PSA is a protein made by the prostate gland that can be elevated due to various conditions including prostate pro... Diagnosis: unknown Cancer Type: unknown Stage: unknown Biomarkers: PSA Key Labs: PSA, total: 4.1 Next Steps: Message your provider about test results, Ask questions about the high PSA result --- DOCUMENT: 2024 PSA.png (Lab Result) Date: [date removed] Summary: This is a PSA (prostate-specific antigen) blood test result showing a total PSA level of 3.95 ng/mL. PSA is a protein made by the prostate gland and is commonly tested to screen for prostate problems.... Diagnosis: unknown Cancer Type: unknown Stage: unknown Biomarkers: PSA Key Labs: PSA, total: 3.95 Next Steps: unknown --- DOCUMENT: 2023 PSA.png (Lab Result) Date: unknown Summary: This is a PSA blood test result showing a total PSA level of 3.23 ng/mL. PSA is a protein made by the prostate gland that can be measured in the blood to help screen for prostate problems. The test wa... Diagnosis: unknown Cancer Type: unknown Stage: unknown Biomarkers: PSA Key Labs: PSA, total: 3.23 Next Steps: unknown --- DOCUMENT: 2022 PSA.png (Lab Result) Date: unknown Summary: This is a PSA (prostate-specific antigen) blood test result showing a total PSA level of 3.6 ng/mL, which is within the normal range of 0.0-4.0 ng/mL. The free PSA is 0.52 ng/mL and the percentage of ... Diagnosis: Unknown - PSA screening results Cancer Type: Prostate screening Stage: unknown Biomarkers: PSA, Free PSA, % Free PSA Key Labs: PSA: 3.6 ng/mL, Free PSA: 0.52 ng/mL, % Free PSA: 14.4% Next Steps: Continue routine monitoring, Follow American Urological Association guidelines --- DOCUMENT: 2020 PSA.png (Lab Result) Date: Feb 06, 2020 Summary: This is a PSA blood test that measures a protein made by the prostate gland. Your PSA level is 1.9 ng/mL, which is within the normal range (less than or equal to 4.0 ng/mL). This suggests no immediate... Diagnosis: PSA screening test Cancer Type: prostate cancer screening Stage: unknown Biomarkers: PSA Key Labs: PSA Total: 1.9 ng/mL Next Steps: Follow routine screening schedule, Discuss results with healthcare provider Return JSON: {"bottomLine":"2-3 sentence summary","keyFindings":["finding1"],"gaps":["gap1"],"questionsForDoctor":["question1"],"timeline":[{"date":"date","event":"event","source":"file"}],"cancerSummary":{"type":"type","stage":"stage","biomarkers":["marker"],"treatments":["treatment"]}}

{
  "bottomLine": "Your PSA has shown a steady upward trend over 5 years, rising from 1.9 in 2020 to 4.22 in October 2025, now exceeding the normal range. The concerning pattern includes both the rising PSA level and a low free PSA percentage of 14%, which may indicate higher risk for prostate cancer and warrants further evaluation.",
  "keyFindings": [
    "PSA has more than doubled from 1.9 ng/mL (2020) to 4.22 ng/mL (October 2025), showing consistent upward trend",
    "Most recent PSA of 4.22 ng/mL exceeds normal range (reference <4.0 ng/mL)",
    "Free PSA percentage is low at 14% (both 2022 and 2025), which may suggest higher risk for prostate cancer",
    "PSA velocity shows concerning pattern with increases: 2020→2022 (+1.7), 2022→2023 (-0.37), 2023→2024 (+0.72), 2024→June 2025 (+0.15), June→Oct 2025 (+0.12)"
  ],
  "gaps": [
    "No prostate biopsy results available despite elevated and rising PSA",
    "Missing digital rectal exam (DRE) findings from urologist",
    "No prostate imaging studies (MRI, ultrasound) documented",
    "PSA density calculation not available (requires prostate volume measurement)",
    "No family history of prostate cancer documented",
    "Missing urologist consultation notes or recommendations for next steps",
    "No documentation of symptoms (urinary changes, pain, etc.)"
  ],
  "questionsForDoctor": [
    "Given my PSA has risen from 1.9 to 4.22 over 5 years with a low free PSA of 14%, do you recommend a prostate biopsy to rule out cancer?",
    "What is my PSA velocity and PSA doubling time, and what do these calculations suggest about my risk?",
    "Should I have a prostate MRI before considering a biopsy, and would you recommend a standard biopsy or MRI-fusion biopsy?",
    "What is my prostate volume from digital rectal exam, and what is my PSA density (PSA level divided by prostate volume)?",
    "Could the rising PSA be explained by benign conditions like prostatitis or enlarged prostate (BPH), and how do we rule those out?",
    "Based on my age and PSA trend, what is my estimated risk of having prostate cancer, and what risk category would I fall into?",
    "If biopsy is recommended, what are the risks and what happens if cancer is found versus if it's not found?",
    "Should I be tested for genetic mutations (BRCA1, BRCA2, ATM, etc.) given the PSA pattern, especially if there's family history of cancer?"
  ],
  "timeline": [
    {
      "date": "2020-02-06",
      "event": "Baseline PSA: 1.9 ng/mL (normal range)",
      "source": "2020 PSA.png"
    },
    {
      "date": "2022",
      "event": "PSA increased to 3.6 ng/mL, Free PSA 14.4% (still within normal range but rising)",
      "source": "2022 PSA.png"
    },
    {
      "date": "2023",
      "event": "PSA: 3.23 ng/mL (slight decrease from 2022)",
      "source": "2023 PSA.png"
    },
    {
      "date": "2024-04-19",
      "event": "PSA: 3.95 ng/mL (approaching upper limit of normal)",
      "source": "2024 PSA.png"
    },
    {
      "date": "2025-06-30",
      "event": "PSA: 4.1 ng/mL (first time exceeding normal range, flagged as high)",
      "source": "June 2025 PSA.png"
    },
    {
      "date": "2025-10-07",
      "event": "PSA: 4.22 ng/mL, Free PSA: 0.61 ng/mL, % Free PSA: 14% (elevated total PSA with low free PSA percentage)",
      "source": "Oct 2025 PSA.png"
    }
  ],
  "cancerSummary": {
    "type": "Prostate cancer screening - no confirmed diagnosis",
    "stage": "Not applicable - no cancer diagnosis confirmed",
    "biomarkers": [
      "PSA (prostate-specific antigen): 4.22 ng/mL (elevated)",
      "Free PSA: 0.61 ng/mL",
      "% Free PSA: 14% (low percentage suggests higher cancer risk)"
    ],
    "treatments": [
      "No treatments - currently in monitoring/screening phase",
      "Next step likely: urologist consultation for possible prostate biopsy or MRI"
    ]
  }
}

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2